Robbie Woodman joined Takeda Ventures, Inc. (TVI) in March 2018, as Senior Partner, and is based in Cambridge, UK. Prior to joining TVI, Robbie was Director of Healthcare Investments at Touchstone Innovations (formerly Imperial Innovations) in London where he led the formation of and investment into a portfolio of UK biotech companies. He was previously a Principal in the life science team at Sofinnova Partners, a leading European venture capital firm. Whilst at Sofinnova, he was actively involved in numerous investments throughout Europe and the US. His experience also includes technology transfer with Cancer Research Technology (CRUK) and pharmaceutical consultancy with IMS Health. Robbie holds an MSc in Biochemistry from the University of Oxford and a Ph.D. in Oncology from the University of Cambridge.